Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Oral Combination Chemotherapy in Conjunction With G-CSF in the Treatment of Elderly Patients With Intermediate and High Grade Non-Hodgkin's Lymphoma
Authors not listed
Case Comprehensive Cancer Center · 1997
Abstract
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving the drugs in different ways may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of oral combination chemotherapy and G-CSF in elderly patients with intermediate- or high-grade non-Hodgkin's lymphomas.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Anonymous. (1997). Oral Combination Chemotherapy in Conjunction With G-CSF in the Treatment of Elderly Patients With Intermediate and High Grade Non-Hodgkin's Lymphoma. <em>Case Comprehensive Cancer Center</em>. https://clinicaltrials.gov/study/NCT00003113
Vancouver
Anonymous. Oral Combination Chemotherapy in Conjunction With G-CSF in the Treatment of Elderly Patients With Intermediate and High Grade Non-Hodgkin's Lymphoma. Case Comprehensive Cancer Center. 1997.
BibTeX
@misc{anon1997OralCo,
title = {Oral Combination Chemotherapy in Conjunction With G-CSF in the Treatment of Elderly Patients With Intermediate and High Grade Non-Hodgkin's Lymphoma},
author = {Anonymous},
journal = {Case Comprehensive Cancer Center},
year = {1997},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cancer Research Campaign Clinical Trials Centre 1992
Open access · US-GOV
A RANDOMIZED PROSPECTIVE TRIAL OF CHOP VERSUS MCOP IN ELDERLY PATIENTS WITH INTERMEDIATE AND HIGH GRADE NON-HODGKIN'S LYMPHOMA (AGED 65 YEARS AND OVER)
SWOG Cancer Research Network 2001
Open access · US-GOV
Protocol for Assessment of Gemcitabine and Paclitaxel for Metastatic Urothelial Cancer in Patients Aged 70 Years or Older (and in a Cohort of Patients Younger Than 60 Years)
Memorial Sloan Kettering Cancer Center 2003
Open access · US-GOV
A Phase II Study of R-CHOP and Ibritumomab Tiuxetan (Zevalin) for Elderly Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
Commissie Voor Klinisch Toegepast Onderzoek 2001
Open access · US-GOV
A Randomized Phase III Study Of Chimeric Anti-CD20 Monoclonal Antibody (Rituximab) With 2-Weekly CHOP Chemotherapy In Elderly Patients With Intermediate Or High-Risk Non-Hodgkin's Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 2002
Open access · US-GOV
Randomised Trial Comparing Chemotherapy Mit CHOEP (Cyclophosphamid, Doxorubicin, Vincristin, Etoposid Und Prednison) In 21-Day Intervals In Standard And Escalated Doses In Patients Aged 18-60 Years Of Age With Aggresive Non-Hodgkin-Lymphomas Favourable Prognoses
Istituto Nazionale per lo Studio e la Cura dei Tumori 1998
Open access · US-GOV